FDA Approves Moderna mRNA Flu Vaccine mFlusiva For Adults 50 And Older
17h
6
The Food and Drug Administration approved Moderna's mFlusiva, the first mRNA-based seasonal influenza vaccine authorized for adults 50 and older, on Wednesday, August 5, 2026. CBS News